Synaffix B.V.

Class 001: Reagents and bioactive compounds for industrial and scientific use.; Class 005: Pharmaceuticals for the in vivo treatment of a disease in patients.; Class 042: Chemical and/or enzymatic modification of proteins.; Class 044: Medical analysis for the diagnosis and treatment of a condition in patients.

Class 001: Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and chemicals that are organic compounds synthesized by a living organism, for industrial and scientific use; Class 005: Pharmaceuticals for the in vivo treatment of cancer, autoimmune and inflammatory diseases in patients

Reagents and bioactive compounds being cells for industrial and scientific use; Medical analysis for the diagnosis and treatment of cancer in patients; Chemical analysis, research and chemical enzymatic modification of proteins for scientific research purposes

Medical analysis for the diagnosis and treatment of a condition in patients in the nature of medical advisory services

[ Reagents and bioactive compounds, namely, peptides, proteins, glycans, nucleotides, and lipids that are all organic compounds synthesized by a living organism, for industrial and scientific use ] | [ Pharmaceutical preparations for the in vivo treatment of cancer, autoimmune and inflammatory diseases in patients ] | Chemical and biological engineering of biological molecules, with a focus on chemical and enzymatic modification of proteins | Medical analysis for the diagnosis and treatment of a condition in patients in the nature of medical advisory services

[ Pharmaceuticals for the in vivo treatment of cancer, autoimmune and inflammatory diseases in patients ]; [ Reagents and bioactive compounds, being peptides, proteins, glycans, nucleotides, lipids and chemicals that are organic compounds synthesized by a living organism, for industrial and scientific use ]; Medical analysis for the diagnosis and treatment of a condition in patients in the nature of medical advisory services; Chemical and biological engineering of biological molecules, with a focus on chemical and enzymatic modification of proteins

[ Reagents for industrial and scientific use; bioactive compounds in the nature of glycoproteins for industrial and scientific use ]; Medical services, namely, medical analysis for the diagnosis and treatment of patients in the field of oncology and immunology; Chemical and biological research, analysis and engineering with a focus on chemical and enzymatic modification of proteins

[ Pharmaceutical preparations for the in vivo treatment of cancer, autoimmune and inflammatory diseases in patients ]; [ Reagents for scientific use; reagents for industrial use, namely, strained cyclooctynes, for the use in cycloaddition reactions with dipoles for the preparation of triazole-containing conjugates such as, for example, antibody drug conjugates; bioactive glycoproteins for industrial and scientific use, namely, for diagnosis and treatment of patients in the field of oncology and immunology ]; Medical services, namely, medical analysis for the diagnosis and treatment of patients in the field of oncology and immunology; Chemical engineering, namely, chemical and/or enzymatic modification of proteins